Marcus Lind

8.0k citations
135 papers · 5.1k · 3 hit papers · h-index 34

Impact in

    • Diabetes Management and Research
    • Diabetes Treatment and Management
    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Genetics top 1%
    • Diabetes and associated disorders

Papers in

    • Diabetes Management and Research 96
    • Diabetes Treatment and Management 78
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 17
    • Diabetes, Cardiovascular Risks, and Lipoproteins 15
    • Pancreatic function and diabetes 32

Marcus Lind

126 papers receiving 5.0k citations

Marcus Lind's Hit Papers

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections 2017 · 529 citations
5290+4+8Years since publication200400600

Peers

Marcus Lind
Comparison fields: 5 of 112
  • Endocrinology, Diabetes and Metabolism 3.9k
  • Genetics 1.4k
  • Cardiology and Cardiovascular Medicine 1.0k
  • Surgery 1.6k
  • Nephrology 191
Replace Ann‐Marie Svensson with:
Ann‐Marie Svensson Sweden
Aldina Pivodic Sweden
Thomas Danne Germany
Marc Evans United Kingdom
Stefan Franzén Sweden
Andrea O. Y. Luk Hong Kong
Kathleen Dungan United States
Daniel Einhorn United States
Jeffrey L. Probstfield United States
Jane L. Chiang United States
Marcus Lind relative to Ann‐Marie Svensson Sweden Ann‐Marie Svensson's profile →
Citations per field
00.5×1.5×
Ann‐Marie Svensson · 1×
Citations per year

Countries citing papers authored by Marcus Lind

Since Specialization
Citations

This map shows the geographic impact of Marcus Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Lind more than expected).

Fields of papers citing papers by Marcus Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Lind. The network helps show where Marcus Lind may publish in the future.

Co-authors

The 25 scholars most cited alongside Marcus Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcus Lind Line = papers co-authored together Marcus Lind links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Excess Mortality among Persons with Type 2 Diabetes
Hit paper breakdown →
2015721
2
Glycemic Control and Excess Mortality in Type 1 Diabetes
Hit paper breakdown →
2014673
3
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
Hit paper breakdown →
2017529
4 2011214
5 2017135
6 2013134
7 2019103
8 202197
9 201893
10 202090
11 201280
12 202175
13 201774
14 201072
15 201470
16 200969
17 201167
18 201966
19 201562
20 201560

About Marcus Lind

Marcus Lind is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 135 papers that have together received 5.1k indexed citations. Recurring topics across this work include Diabetes Management and Research (96 papers), Diabetes Treatment and Management (78 papers), Pancreatic function and diabetes (32 papers), Diabetes and associated disorders (31 papers), Cardiovascular Function and Risk Factors (18 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (17 papers), Metabolism, Diabetes, and Cancer (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.9k citations), Genetics (1.4k citations), Cardiology and Cardiovascular Medicine (1.0k citations), Surgery (1.6k citations) and Nephrology (191 citations). Marcus Lind has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Ann‐Marie Svensson, Annika Rosengren, Aldina Pivodic, Sofia Dahlqvist, Soffia Guðbjörnsdóttir, Hans Wedel, Mikhail Kosiborod, Mark A. Clements, Arndís F. Ólafsdóttir and Björn Eliasson. Their work appears in journals such as Diabetes Care, Journal of Diabetes Science and Technology, BMJ Open Diabetes Research & Care, Diabetes Technology & Therapeutics and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact